INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2003

A review proposes that food-derived opioid peptides (exorphins) and serotonin uptake modulators in urine may mediate autism pathophysiology.

This review presents an autism model based on the discovery of food protein-derived opioid peptides (exorphins) in the urine of autistic patients. The authors suggest that exorphins and serotonin uptake-stimulating factors may explain many signs, symptoms, and behavioural effects seen in autistic disorders. They propose that these compounds are key mediators of autism development, potentially caused by genetically based peptidase deficiencies triggered by dietary overload of exorphin precursors or increased gut uptake.

Study type
Narrative review / proposed disease model
Who was studied
Autistic patients (referenced across multiple groups)
What was measured
Pathophysiology and signs/symptoms of autism explained by urine peptides

THE PAPER

Can the pathophysiology of autism be explained by the nature of the discovered urine peptides?

Reichelt KL, Knivsberg AM. Nutr Neurosci, 2003.

PubMed 12608733 ↗DOI 10.1080/1028415021000042839 ↗

Gut & microbiomeBrain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.